about
Replication of human immunodeficiency virus 1 and Moloney murine leukemia virus is inhibited by different heteroatom-containing analogs of myristic acidCCR5 gene disruption via lentiviral vectors expressing Cas9 and single guided RNA renders cells resistant to HIV-1 infectionAbsence of XMRV in peripheral blood mononuclear cells of ARV-treatment naïve HIV-1 infected and HIV-1/HCV coinfected individuals and blood donors.GPI-anchored single chain Fv--an effective way to capture transiently-exposed neutralization epitopes on HIV-1 envelope spike.Relative replication capacity of phenotypic SIV variants during primary infections differs with route of inoculation.Development of leukemia in mice transgenic for the tax gene of human T-cell leukemia virus type I.Integration of human immunodeficiency virus type 1 in untreated infection occurs preferentially within genes.The viral restriction factor tetherin prevents leucine-rich pentatricopeptide repeat-containing protein (LRPPRC) from association with beclin 1 and B-cell CLL/lymphoma 2 (Bcl-2) and enhances autophagy and mitophagy.Potent and broad anti-HIV-1 activity exhibited by a glycosyl-phosphatidylinositol-anchored peptide derived from the CDR H3 of broadly neutralizing antibody PG16.Subversion of Cell Cycle Regulatory Mechanisms by HIV.Suppression of viremia and evolution of human immunodeficiency virus type 1 drug resistance in a macaque model for antiretroviral therapy.HIV-1 fitness and disease progression: insights from the SIV-macaque model.A variant macaque-tropic human immunodeficiency virus type 1 is resistant to alpha interferon-induced restriction in pig-tailed macaque CD4+ T cellsA decrease in albumin in early SIV infection is related to viral pathogenicityThe Glycosylphosphatidylinositol-Anchored Variable Region of Llama Heavy Chain-Only Antibody JM4 Efficiently Blocks both Cell-Free and T Cell-T Cell Transmission of Human Immunodeficiency Virus Type 1.Stepping toward a macaque model of HIV-1 induced AIDS.Challenges and strategies for the eradication of the HIV reservoir.Emerging cytopathic and antigenic simian immunodeficiency virus variants influence AIDS progression.Progression to AIDS in macaques is associated with changes in the replication, tropism, and cytopathic properties of the simian immunodeficiency virus variant population.Capture and transfer of simian immunodeficiency virus by macaque dendritic cells is enhanced by DC-SIGN.ICAM-3 influences human immunodeficiency virus type 1 replication in CD4(+) T cells independent of DC-SIGN-mediated transmission.Domains of macaque DC-SIGN essential for capture and transfer of simian immunodeficiency virus.Construction and characterization of infectious human T-cell leukemia virus type 1 molecular clones.HIV replication in conjunction with granzyme B production by CCR5+ memory CD4 T cells: Implications for bystander cell and tissue pathologies.Identification of a simian immunodeficiency virus reverse transcriptase variant with enhanced replicational fidelity in the late stage of viral infection.CD3-dependent lymphocyte activation by human T cell leukaemia virus type I-producing T cells.Highly Pathogenic Simian Immunodeficiency Virus mne Variants That Emerge during the Course of Infection Evolve Enhanced Infectivity and the Ability To Downregulate CD4 but Not Class I Major Histocompatibility Complex Antigens.Distinct susceptibility of HIV vaccine vector-induced CD4 T cells to HIV infection.
P50
Q28359721-41A11961-8CC7-4A3D-AE37-14D469C45854Q28542878-A01EC52F-E344-4308-8BE2-B35B50415CB5Q34163532-FCABD815-4E4F-460A-9F3D-EAF0A6634BBAQ34221625-61A74AF4-9A66-457B-B853-FE95280503F3Q34243486-84B6ADA3-6EB7-4848-8D58-69167DC2C634Q34680906-9E919AAF-F4A7-4118-AD0A-89AF26FC2755Q35023783-C15E95BF-7561-4369-A762-39666DC5B4C5Q35172704-E8E08A24-E5DA-4D9E-85B1-0A428627EB87Q35192886-21473B8B-C52E-42E5-A623-11942DC89B2BQ35767091-7BCA3C8F-522D-41EA-ACC7-93D256CD7E48Q36315555-362BCE1C-BE65-47BA-889A-55D231D80BECQ36384847-4A7BD436-ED95-467B-9715-CCF58DC3EEF3Q36911742-35DA9538-BCEA-4ED7-95DA-5112246D5855Q37401958-0A071789-2049-4076-AC1A-C5091E06B451Q37415455-C437A363-38AB-4360-B54F-EBA077685AEEQ38254353-79F99159-15D0-4059-9BE1-842DE1CCEBF7Q38862056-2D5945A5-3B5A-4D70-8B53-D5AC3AA219E5Q39137553-32798FAB-C04F-49B0-BCD4-9E0EF3CBE2C8Q39413139-55B117B2-E423-49CE-8745-7C194795C59FQ39686227-B716B746-51AD-4D3E-BF5C-8BF25B8FC85AQ40145728-0A42C2C5-05E5-466F-9012-90A57E6F90DFQ40548346-A4A1526A-F888-45C3-A653-F090CEF4E8B0Q41431402-BA9A4166-D81E-470C-9C63-23CA7135472DQ42207253-409C293A-9EE8-4F05-95F2-21F7A4E37BF6Q44160944-01D7C34D-FE4A-4388-9E15-DE726833FCF7Q45783121-605B9F42-C264-4DA2-91D3-FB52D13275F8Q50425094-4D8F343C-A3E7-4175-B9C0-0B40E717248EQ52730779-049F4392-B708-4A3B-9842-C5C120033C03
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Jason T. Kimata
@ast
Jason T. Kimata
@en
Jason T. Kimata
@es
Jason T. Kimata
@nl
Jason T. Kimata
@sl
type
label
Jason T. Kimata
@ast
Jason T. Kimata
@en
Jason T. Kimata
@es
Jason T. Kimata
@nl
Jason T. Kimata
@sl
prefLabel
Jason T. Kimata
@ast
Jason T. Kimata
@en
Jason T. Kimata
@es
Jason T. Kimata
@nl
Jason T. Kimata
@sl
P106
P1153
6603900009
P31
P496
0000-0002-0504-0090